Best EHA Podcasts (2024)

1
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP? 53:33

12d ago53:33

53:33

touchCONGRESS for touchHAEMATOLOGY Listen to immune thrombocytopenia (ITP) expert Dr Vickie McDonald review key data presented at the European Hematology Association (EHA) and International Society on Thrombosis and Haemostasis (ISTH) 2024 congresses on the impact and current and future management of ITP. She is joined by two additional leading ITP…

1
"Rhythms of Resilience: Ezra Barnett's Journey from Trench Town to Global Stages" 48:12

13h ago48:12

48:12

In this episode of the Stories to Create Podcast, Cornell Bunting reconnects with his high school friend, Ezra Barnett, a talented drummer, carpenter, designer, and musician from Kingston, Jamaica. Ezra shares his incredible journey, starting from his early years in the tough streets of Trench Town in the 1980s. He discovered his love for the arts …

1
Global perspectives on blood cancers: addressing disparities in awareness, diagnosis, and treatment 18:54

4d ago18:54

18:54

Welcome to the first episode of VJHemOnc's Blood Cancer Awareness Month special series! This episode focuses on global perspectives of blood cancers and addresses the disparities that exist in awareness, diagnosis, and treatment. First, Lalit Kumar, MD, MBBS, Artemis Hospital, New Delhi, India, discusses challenges that exist in the management of b…

1
The Rise of the Machines: A Quickfire Exploration of Artificial Intelligence and Big Data in Oncology 17:51

4d ago17:51

17:51

Did you know that artificial intelligence (AI) is shaping the future of oncology? Our expert faculty discuss in this rapid question and answer program! Credit available for this activity expires: 9/6/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001549?ecd=bdc_podcast_libsyn_mscpedu…

1
"Building Bridges: From Haiti to Success in America with Wes Moussignac" 47:03

6d ago47:03

47:03

On this episode of the Stories to Create podcast, Cornell Bunting sits down with businessman and entrepreneur Wes Moussignac to discuss his journey and work in Southwest Florida. Born in Port-au-Prince, Haiti, Wes shares how he grew up in what he described as the slums and left Haiti at around eight years old due to the violence caused by rebels in…

1
Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape 17:37

9d ago17:37

17:37

In this podcast episode, Dr. Versha Banerji discusses the role of non-covalent BTK inhibitors for the treatment of CLL. Our Guest: Dr. Versha Banerji is a Clinician Scientist at CancerCare Manitoba and Senior Scientist at the Research Institute in Oncology and Hematology, based in Winnipeg, Manitoba. If you enjoyed our podcast episode, please revie…

1
Insights into PV and ET: treating the AYA population, defining goals when treating patients, & more 11:50

11d ago11:50

11:50

Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms (MPNs) characterized by the overproduction of red blood cells and platelets, respectively, due to mutations in hematopoietic stem cells. In this podcast, experts Andrew Kuykendall, MD, Moffitt Cancer Center, Tampa, FL; Lucia Masarova, MD, The University of Te…

1
"Rising from Adversity: Mrs. Universe Jamaica 2024 Annieka Francis on Triumph, Vision, and Empowering Youth" 41:41

13d ago41:41

41:41

On the latest Stories to Create Podcast episode, Cornell Bunting interviews Mrs. Annieka Francis, the newly crowned Mrs. Universe Jamaica 2024. Born in Kingston, Jamaica, Annieka grew up in Coreville Garden, where she fondly recalls attending her father's cricket matches and meeting the legendary Brian Lara, who played alongside her dad. As a child…

1
Chikungunya Virus Vaccine: A New Addition to the Travel Vaccine Armamentarium 31:22

14d ago31:22

31:22

Do you know how to identify individuals at risk for chikungunya virus-related disease who may benefit from vaccination? Credit available for this activity expires: 8/29/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001434?ecd=bdc_podcast_libsyn_mscpedu

1
Undercover Partners: HIV, Immune Activation, and Inflammation 27:04

18d ago27:04

27:04

Find out how to assess inflammation in people living with HIV, and how it drives early aging and comorbidities. Credit available for this activity expires: 8/29/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001461?ecd=bdc_podcast_libsyn_mscpedu

1
Episode 50. Quadruplets in Newly Diagnosed Transplant-Ineligible Myeloma with Dr. Timothy Schmidt 41:39

15d ago41:39

41:39

In this episode, we discuss the management of newly diagnosed transplant in-eligible multiple myeloma with Dr. Timothy Schmidt, with a special focus on IMROZ and BENEFIT RCTs testing quadruplets in this space. Here are the key papers we discussed: 1. MAIA trial (Daratumumab-Lenalidomide-Dexamethasone [DRd] vs Rd in newly diagnosed transplant inelig…

1
Continuous glucose monitoring in type 2 diabetes: Overcoming barriers to optimize outcomes 41:33

15d ago41:33

41:33

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of experts discuss the benefits of CGM in patients with T2D, strategies to overcome the barriers to its uptake and how to best support patients in implementing CGM. The experts Prof. Stewart Harris, Western University, London, Ontario, Canada, Dr Anders Carlson, International Diabetes C…

1
Patient-Centered Care in Newly Diagnosed Multiple Myeloma: Navigating Triplet and Quadruplet Therapy 32:22

25d ago32:22

32:22

Did you know that choosing between triplet and quadruplet regimens can make a significant difference in achieving optimal disease outcomes? Credit available for this activity expires: 08/19/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001477?ecd=bdc_podcast_libsyn_mscpedu…

1
Hemophilia updates from ISTH 2024: ongoing clinical trials, emerging gene therapies & remaining challenges 18:41

25d ago18:41

18:41

This week's VJHemOnc podcast brings you updates in hemophilia from the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Bangkok, Thailand, and virtually. You hear from experts Omolade Awodu, MBChB, MD, FMCPath, University of Benin, Benin City, Nigeria, who discusses key hemophilia clinical trials in 2024, Rad…

1
Personalizing care within the MDT for patients with early through to advanced RCC 19:36

25d ago19:36

19:36

touchFOCUS for touchONCOLOGY Listen to Prof. Hans Hammers as he answers a series of questions on the application of prognostic markers and clinical data within the multidisciplinary team to personalize care for patients with early stage through to advanced and metastatic RCC. In addition, he responds to questions on the use of effective communicati…

1
"Voices of Resilience: The Journey of Zale Young" 44:46

1M ago44:46

44:46

In this episode of the Stories to Create Podcast, host Cornell Bunting chats with Zale Young, an up-and-coming reggae artist based in California, striving to break into the music industry with his unique and diverse style. Zale shares his journey of growing up in Kingston with his mother, surrounded by the Rastafarian community in the early 2000s. …

1
Selecting Antiseizure Medications and Aiming for Seizure Freedom 38:05

27d ago38:05

38:05

How to achieve seizure freedom after 2 antiseizure medications (ASMs) fail? Expert insight into best practice Credit available for this activity expires: 8/15/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001425?ecd=bdc_podcast_libsyn_mscpedu

1
Advances in Dermal Fillers: Hybrid Fillers and the Power of Regenerative Biostimulation 32:15

1M ago32:15

32:15

Learn the fundamentals of regenerative aesthetics and how hybrid fillers can help you achieve patient goals. Credit available for this activity expires: 8/15/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001440?ecd=bdc_podcast_libsyn_mscpedu

1
Selecting ART: Working with people living with HIV to find the best regimen 39:45

29d ago39:45

39:45

touchIN CONVERSATION for touchINFECTIOUS DISEASES Listen to a conversation between Dr Christoph Boesecke and Dr Tristan Barber, two experts on HIV practising in Germany and the UK. They respond to questions submitted by the HCP audience and provide their insights on best practices for antiretroviral therapy selection for people living with HIV. The…

1
Episode 49. Updates on Low-Risk MDS with Dr. Maximilian Stahl 43:23

1M ago43:23

43:23

In this episode, we discuss updates on low-risk MDS with Dr. Maximilian Stahl with a focus on imetelstat and luspatercept. Here are the trials we discussed: 1. IWG 2019 response criteria https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042664/ 2. MEDALIST trial: Luspatercept https://www.nejm.org/doi/10.1056/NEJMoa1908892?url_ver=Z39.88-2003&rfr_id=ori…

1
Inflammation and immune interventions in MDS: targeting STAT, IRAK4, & more 17:29

1M ago17:29

17:29

In myelodysplastic syndromes (MDS), chronic inflammation driven by the innate immune system plays a key role in disease progression. Signal Transducer and Activator of Transcription (STAT) and Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) are critical mediators in this process, where dysregulated signaling leads to aberrant hematopoiesis and t…

1
Treatment Goals and Targeted Therapies in Myasthenia Gravis 31:03

1M ago31:03

31:03

Are you up to date on the most recent clinical guidelines and treatment options for myasthenia gravis (MG)? Credit available for this activity expires: 8/6/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001404?ecd=bdc_podcast_libsyn_mscpedu

1
Thyroid eye disease: An evolving continuum of care 38:00

1M ago38:00

38:00

touchPANEL DISCUSSION for touchOPHTHALMOLOGY Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk factors, symptomatology and burden of disease in affected patients, as well as the process for screening and diagnosing the disease. The experts Dr Andrea Kossler, Stanford University School of Med…

1
EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway 37:22

1M ago37:22

37:22

How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024. Credit available for this activity expires: 07/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001409 ?ecd=bdc_podcast_libsyn_msc…

1
Updates in the treatment of SCD and thalassemia from EHA 2024: key trial updates, challenges with gene therapies & unmet needs 11:58

1M ago11:58

11:58

Today’s VJHemOnc podcast features experts Rabi Hanna, MD, The Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, Subarna Chakravorty, MBBS, MRCPCH, FRCPath, PhD, King’s College Hospital NHS Foundation Trust, London, UK, and Ali Taher, MD, PhD, FRCP, American University of Beirut Medical Center, Beirut, Lebanon. They discuss key updates in si…

1
Intracranial haemorrhage related to direct oral anticoagulant medications: Latest evidence for reversal strategies 47:09

1M ago47:09

47:09

touchTALKS for touchNEUROLOGY A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition. The expert Prof. Dr. me…

1
"From Humble Beginnings to Real Estate: David Harrison's Journey" 51:41

2M ago51:41

51:41

On this episode of the Stories to Create Podcast, Cornell Bunting sits down with real estate mogul David Harrison, who has extensive experience serving customers in Florida, Jamaica, and Georgia. David is committed to providing exceptional service to individuals and families looking to buy, sell, build, invest, or rent. His expertise spans South Fl…

1
Expanding the reach of HER2 in solid tumours: A spotlight on tumour-agnostic approaches 16:01

1M ago16:01

16:01

touchFOCUS for touchONCOLOGY Listen to Dr Dana Chase discuss the role of HER2 as a pan-tumour biomarker and the implications for treatment across various cancer types. The expert Dr Dana Chase - UCLA Health, Los Angeles, CA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from AstraZeneca. T…

1
The Immersive Immigrant with Lindy Mtongana 1:06:16

2M ago1:06:16

1:06:16

In this episode of the "Home to Here" podcast, we dive into the fascinating journey of Lindy Mtongana, an immersive immigrant from South Africa. Throughout the episode, Lindy provides valuable insights into the immigrant experience, highlighting the importance of community and the unique challenges that come with adapting to a new culture. She also…

1
Managing Diffuse Large B-Cell Lymphoma at First Relapse: Optimizing Patient-Centered Care 38:15

1M ago38:15

38:15

Learn from the experts about aligning treatments with patient expectations at first relapse of diffuse large B-cell lymphoma (DLBCL). Credit available for this activity expires: 7/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001321?ecd=bdc_podcast_libsyn_mscpedu…

1
The path from detection to personalized long-term care for Fabry disease 36:05

1M ago36:05

36:05

touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions. The experts Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic Dr Eric Wallace, University of Alabama at Birmingham Scho…

1
Demystifying virology: The link between the HIV life cycle and ART 37:54

2M ago37:54

37:54

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES Listen to leading experts describe the HIV life cycle, the rationale for multidrug antiretroviral therapy (ART) regimens, mechanisms of ART resistance and how to manage it in people living with HIV. The experts Prof. Anne-Mieke Vandamme - Katholieke Universiteit Leuven, Belgium Prof. José Arribas - …

1
Knowledge for nurses ADC updates in breast cancer 40:21

1M ago40:21

40:21

touchIN CONVERSATION for touchONCOLOGY Listen to Ms Nikolina Dodlek, an oncology nurse from Croatia, in conversation with Professor Sherko Kümmel, a leading medical oncologist from Germany. They respond to questions submitted by the HCP audience and provide their expert insights on the use of HER2-directed antibody–drug conjugates (ADCs) in the tre…

1
A transcriptional cofactor‐mediated dependency module 24:48

2M ago24:48

24:48

In this newest podcast episode, Dr Charles de Bock hosts Dr Thomas Mercher and Dr Alexandre Fagnan. This episode is based on their recent paper, “The ETO2 transcriptional co-factor maintains acute leukemia by driving a MYB/EP300-dependent stemness program”, highlighting ETO2 activated gene transcription and how this affects erythroleukemia. The dis…

1
Unmet treatment needs in MF: managing prefibrotic disease & thrombocytopenia, novel agents & endpoints for clinical trials 16:00

2M ago16:00

16:00

Myelofibrosis (MF) is a chronic myeloproliferative neoplasm (MPN) characterized by bone marrow fibrosis, extramedullary hematopoiesis, and splenomegaly, often resulting in anemia and thrombocytopenia. There are many unmet treatment needs that remain in this space. This week’s podcast features a discussion from the International Workshop on Myelodys…

1
"Navigating Paradigm Shifts: A Conversation with Bernard Faithful" 59:19

2M ago59:19

59:19

In this episode of the Stories to Create Podcast, host Cornell Bunting welcomes back repeat guest Bernard Faithful. Born and raised in Michigan, Bernard has traveled the world as a professional athlete. Before his athletic career, he attended the University of Toledo, earning a bachelor's degree in psychology. He later achieved a master’s degree in…

1
Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma 39:16

2M ago39:16

39:16

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key consideratio…

1
Incorporating Lipoprotein(a) Routinely Into Cardiovascular Risk Assessment: Why, What, Who, How, and When? 18:49

2M ago18:49

18:49

Learn from the experts about typical clinical scenarios, guidelines, and practical tips about lipoprotein(a) [Lp(a)]. Credit available for this activity expires: 7/24/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001247?ecd=bdc_podcast_libsyn_mscpedu

1
The Intentional Immigrant with Ehae Longe 1:01:40

2M ago1:01:40

1:01:40

In this insightful episode of Home 2 Here, we sit down with Ehae Longe, a remarkable individual who has navigated cultural transitions from Nigeria to England and then to France. Ehae shares her journey from finishing high school in Lagos to moving to the UK for college, highlighting the challenges and triumphs she faced along the way. She discusse…

1
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies 37:31

2M ago37:31

37:31

touchIN CONVERSATION for touchRESPIRATORY Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments. The experts Prof. Enriqueta Felip - Medical Oncol…

1
The role of BTK inhibitors in MCL, ongoing trials & future outlooks: updates from EHA 2024 12:13

2M ago12:13

12:13

The introduction of Bruton's tyrosine kinase (BTK) inhibitors into the treatment landscape for mantle cell lymphoma (MCL) has transformed the field and provided patients with a promising therapeutic option. In this podcast, you will hear from leading experts who discuss the value of these agents in MCL, sharing updates from EHA 2024. Tune in as Man…

1
Episode 48. Management of Polycythemia Vera with Dr. Aaron Gerds 57:09

2M ago57:09

57:09

In this episode, we discussed the diagnosis and management of polycythemia vera with Dr. Aaron T. Gerds. Here are the shownotes with the key studies discussed: 1. MIPS PV scoring system https://pubmed.ncbi.nlm.nih.gov/31945802/ 2. REVEAL study https://ashpublications.org/blood/article/143/16/1646/506717/Association-between-elevated-white-blood-cell…

1
Early diagnosis and treatment of NMOSD: Practical insights 40:30

2M ago40:30

40:30

touchIN CONVERSATION for touchNEUROLOGY - Early diagnosis and treatment of NMOSD: Practical insights Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting sympt…

Podcasts Worth a Listen

EHA Podcasts

Podcasts Worth a Listen

Quick Reference Guide